Edition:
India

SAGE Therapeutics Inc (SAGE.OQ)

SAGE.OQ on NASDAQ Stock Exchange Global Market

166.71USD
18 Jan 2018
Change (% chg)

-- (--)
Prev Close
$166.71
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
307,042
52-wk High
$180.50
52-wk Low
$44.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.00 -1.879
Mar '17 0.00 -1.523
FY 2016 Dec '16 0.00 -1.498
Sep '16 0.00 -1.146
Jun '16 0.00 -1.084
Mar '16 0.00 -0.965
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 7 0.00 0.00 0.00 --
Quarter Ending Jun-18 7 0.00 0.00 0.00 --
Year Ending Dec-18 14 9.98 57.40 0.00 53.58
Earnings (per share)
Quarter Ending Mar-18 7 -2.00 -1.79 -2.26 --
Quarter Ending Jun-18 7 -2.19 -1.79 -2.74 --
Year Ending Dec-18 13 -8.29 -6.59 -10.97 -4.19
LT Growth Rate (%) 1 -15.20 -15.20 -15.20 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -39.54 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for SAGE Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 264
Total Shares Held: 41,912,148
3 Mo. Net Change: 25,071
# New Positions: 4
# Closed Positions: 4
# Increased Positions: 14
# Reduced Positions: 12
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.